Skip to main content

and
  1. Article

    Open Access

    Dynamics and durability of HIV-1 neutralization are determined by viral replication

    Human immunodeficiency virus type 1 (HIV-1)-neutralizing antibodies (nAbs) that prevent infection are the main goal of HIV vaccine discovery. But as no nAb-eliciting vaccines are yet available, only data from ...

    Philipp Schommers, Dae Sung Kim, Maike Schlotz, Christoph Kreer in Nature Medicine (2023)

  2. No Access

    Article

    Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV

    Recombinant vesicular stomatitis virus–Zaire Ebola virus (rVSV-ZEBOV) is the most advanced Ebola virus vaccine candidate and is currently being used to combat the outbreak of Ebola virus disease (EVD) in the D...

    Stefanie A. Ehrhardt, Matthias Zehner, Verena Krähling in Nature Medicine (2019)